The assessment of high sensitivity cardiac troponin in patients with COVID-19: A multicenter study
Background: Recent studies have shown that patients diagnosed with coronarivus disease 2019 (COVID-19) and also with previous cardiovascular diseases have a higher mortality due to worsening heart disease. At the same time, patients without previous cardiovascular disease may also have cardiac compl...
Main Authors: | Marco Alfonso Perrone, Federica Spolaore, Massimiliano Ammirabile, Francesco Romeo, Patrizio Caciagli, Ferruccio Ceriotti, Sergio Bernardini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906721000038 |
Similar Items
-
Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis
by: Saikrishna Reddy, et al.
Published: (2020-01-01) -
Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1
by: Aleksey M. Chaulin
Published: (2021-09-01) -
Clinical Utility of Cardiac Troponin I and Cardiac Troponin T Measurements
by: Michaela Adamcová, et al.
Published: (1997-01-01) -
Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study
by: Romaric Larcher, et al.
Published: (2021-04-01) -
Cardiac troponin elevation in patients with influenza virus infections
by: Giuseppe Lippi, et al.
Published: (2021-04-01)